Stage-specific embryonic antigen (SSEA) expression is used to describe the differentiation state of an embryonic stem cell (ESC). In human ESCs, SSEA-3 and SSEA-4 are highly expressed in undifferentiated cells and downregulated upon differentiation. SSEA-4 has also been described as a marker for adult stem cells in various tissues, including human neonatal cardiac tissue. However, there is currently little data on the expression of SSEAs in human adult cardiac tissue. We obtained right and left atrial biopsies from patients undergoing cardiac surgery. These were dissociated, stained for SSEAs and other cardiac stem cell markers and analyzed by flow cytometry. Directly isolated cells expressed variable levels of SSEA-1, SSEA-3 and SSEA-4. The SSEA-1+ population was established as contaminating hematopoietic cells. The SSEA-4+ population, on the other hand, could be subdivided based on the endothelial progenitor marker CD34. The SSEA-4+ CD34- population in the right atrium had a high gene expression of both early (TBX5, NKX2.5) and late (TNNT2) cardiomyocyte markers. The SSEA-4+ CD34+ population, on the other hand, overlapped with previously described C-kit+ CD45- cardiac stem cells. Primary monolayer-cultured cells retained expression of SSEAs while the cardiomyogenic specification in the SSEA-4+ CD34- population was lost. In tissue sections, SSEA-4+ cells could be identified both within and outside the myocardium. Within the myocardium, some SSEA-4+ cells coexpressed cardiomyogenic markers. In conclusion, the results show that the adult human heart expresses SSEAs and that there is a subpopulation of SSEA-4+ CD34- cells that show features of a cardiomyocyte progenitor population.

Keywords:
Fluorescence-activated cell sorting, Cardiac stem cells, Maze surgery, Stage-specific embryonic antigens
1.
Amir, G., X. Ma, V.M. Reddy, F.L. Hanley, O. Reinhartz, C. Ramamoorthy, R.K. Riemer (2008) Dynamics of human myocardial progenitor cell populations in the neonatal period. Ann Thorac Surg 86: 1311-1319.
2.
Arminan, A., C. Gandia, M. Bartual, J.M. Garcia-Verdugo, E. Lledo, V. Mirabet, M. Llop, J. Barea, J.A. Montero, P. Sepulveda (2009) Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev 18: 907-918.
3.
Bearzi, C., M. Rota, T. Hosoda, J. Tillmanns, A. Nascimbene, A. De Angelis, S. Yasuzawa-Amano, I. Trofimova, R.W. Siggins, N. Lecapitaine, S. Cascapera, A.P. Beltrami, D.A. D'Alessandro, E. Zias, F. Quaini, K. Urbanek, R.E. Michler, R. Bolli, J. Kajstura, A. Leri, P. Anversa (2007) Human cardiac stem cells. Proc Natl Acad Sci USA 104: 14068-14073.
4.
Beltrami, A.P., L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, K. Urbanek, A. Leri, J. Kajstura, B. Nadal-Ginard, P. Anversa (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
5.
Bergmann, O., R.D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabe-Heider, S. Walsh, J. Zupicich, K. Alkass, B.A. Buchholz, H. Druid, S. Jovinge, J. Frisen (2009) Evidence for cardiomyocyte renewal in humans. Science 324: 98-102.
6.
Bondue, A., C. Blanpain (2010) Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 107: 1414-1427.
7.
Cox, J.L., J.P. Boineau, R.B. Schuessler, R.D. Jaquiss, D.G. Lappas (1995) Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. J Thorac Cardiovasc Surg 110: 473-484.
8.
D'Amario, D., C. Fiorini, P.M. Campbell, P. Goichberg, F. Sanada, H. Zheng, T. Hosoda, M. Rota, J.M. Connell, R.P. Gallegos, F.G. Welt, M.M. Givertz, R.N. Mitchell, A. Leri, J. Kajstura, M.A. Pfeffer, P. Anversa (2011) Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 108: 857-861.
9.
Draper, J.S., C. Pigott, J.A. Thomson, P.W. Andrews (2002) Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200: 249-258.
10.
Emmert, M.Y., L.S. Emmert, A. Martens, I. Ismail, I. Schmidt-Richter, A. Gawol, B. Seifert, A. Haverich, U. Martin, I. Gruh (2012) Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium. Eur Heart J 34: 2830-2838.
11.
Everett, T.H.t., J.E. Olgin (2007) Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4(suppl 3): S24-S27.
12.
Fenderson, B.A., M.P. De Miguel, A.D. Pyle, P.J. Donovan (2006) Staining embryonic stem cells using monoclonal antibodies to stage-specific embryonic antigens. Methods Mol Biol 325: 207-224.
13.
Gang, E.J., D. Bosnakovski, C.A. Figueiredo, J.W. Visser, R.C. Perlingeiro (2007) SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109: 1743-1751.
14.
Genead, R., C. Danielsson, A.B. Andersson, M. Corbascio, A. Franco-Cereceda, C. Sylven, K.H. Grinnemo (2010) Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev 19: 1601-1615.
15.
Goumans, M.J., T.P. de Boer, A.M. Smits, L.W. van Laake, P. van Vliet, C.H. Metz, T.H. Korfage, K.P. Kats, R. Hochstenbach, G. Pasterkamp, M.C. Verhaar, M.A. van der Heyden, D. de Kleijn, C.L. Mummery, T.A. van Veen, J.P. Sluijter, P.A. Doevendans (2007) TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 1: 138-149.
16.
Gron, B., A. Andersson, E. Dabelsteen (1999) Blood-group-related carbohydrates are expressed in organotypic cultures of human skin and oral mucosa. APMIS 107: 779-790.
17.
Itzhaki-Alfia, A., J. Leor, E. Raanani, L. Sternik, D. Spiegelstein, S. Netser, R. Holbova, M. Pevsner-Fischer, J. Lavee, I.M. Barbash (2009) Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation 120: 2559-2566.
18.
Kannagi, R., N.A. Cochran, F. Ishigami, S. Hakomori, P.W. Andrews, B.B. Knowles, D. Solter (1983a) Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2: 2355-2361.
19.
Kannagi, R., S.B. Levery, F. Ishigami, S. Hakomori, L.H. Shevinsky, B.B. Knowles, D. Solter (1983b) New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem 258: 8934-8942.
20.
Kucia, M., R. Reca, F.R. Campbell, E. Zuba-Surma, M. Majka, J. Ratajczak, M.Z. Ratajczak (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 20: 857-869.
21.
Li, Q., Y. Guo, Q. Ou, N. Chen, W.J. Wu, F. Yuan, E. O'Brien, T. Wang, L. Luo, G.N. Hunt, X. Zhu, R. Bolli (2011) Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol 106: 849-864.
22.
Matsuura, K., T. Nagai, N. Nishigaki, T. Oyama, J. Nishi, H. Wada, M. Sano, H. Toko, H. Akazawa, T. Sato, H. Nakaya, H. Kasanuki, I. Komuro (2004) Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279: 11384-11391.
23.
Miyamoto, S., N. Kawaguchi, G.M. Ellison, R. Matsuoka, T. Shin'oka, H. Kurosawa (2010) Characterization of long-term cultured c-kit+ cardiac stem cells (CSCs) derived from adult rat hearts. Stem Cells Dev 19: 105-116.
24.
Mozley, P.D., J.B. Stubbs, S.H. Dresel, E.D. Barraclough, T. Smith, M. Patel, C. Finkelman, R.B. Sparks, M.L. Thakur, A. Mathur, A. Alavi (1999) Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes. J Nucl Med 40: 625-630.
25.
Muramatsu, T., H. Muramatsu (2004) Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J 21: 41-45.
26.
Oerlemans, M.I., M.J. Goumans, B. van Middelaar, H. Clevers, P.A. Doevendans, J.P. Sluijter (2010) Active Wnt signaling in response to cardiac injury. Basic Res Cardiol 105: 631-641.
27.
Ott, H.C., T.S. Matthiesen, J. Brechtken, S. Grindle, S.K. Goh, W. Nelson, D.A. Taylor (2007) The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nat Clin Pract Cardiovasc Med 4(suppl 1): S27-S39.
28.
Oyama, T., T. Nagai, H. Wada, A.T. Naito, K. Matsuura, K. Iwanaga, T. Takahashi, M. Goto, Y. Mikami, N. Yasuda, H. Akazawa, A. Uezumi, S. Takeda, I. Komuro (2007) Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 176: 329-341.
29.
Pfister, O., F. Mouquet, M. Jain, R. Summer, M. Helmes, A. Fine, W.S. Colucci, R. Liao (2005) CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97: 52-61.
30.
Sandstedt, J., M. Jonsson, K. Kajic, M. Sandstedt, A. Lindahl, G. Dellgren, A. Jeppsson, J. Asp (2012) Left atrium of the human adult heart contains a population of side population cells. Basic Res Cardiol 107: 255.
31.
Sandstedt, J., M. Jonsson, A. Lindahl, A. Jeppsson, J. Asp (2010) C-kit+ CD45- cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res Cardiol 105: 545-556.
32.
Schindelin, J., I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J.Y. Tinevez, D.J. White, V. Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676-682.
33.
Sudou, A., H. Muramatsu, T. Kaname, K. Kadomatsu, T. Muramatsu (1997) Le(X) structure enhances myocardial differentiation from embryonic stem cells. Cell structure and function 22: 247-251.
34.
Synnergren, J., T.L. Giesler, S. Adak, R. Tandon, K. Noaksson, A. Lindahl, P. Nilsson, D. Nelson, B. Olsson, M.C. Englund, S. Abbot, P. Sartipy (2007) Differentiating human embryonic stem cells express a unique housekeeping gene signature. Stem Cells 25: 473-480.
35.
van Vliet, P., M. Roccio, A.M. Smits, A.A. van Oorschot, C.H. Metz, T.A. van Veen, J.P. Sluijter, P.A. Doevendans, M.J. Goumans (2008) Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J 16: 163-169.
36.
Vukusic, K., M. Jonsson, C. Brantsing, G. Dellgren, A. Jeppsson, A. Lindahl, J. Asp (2013) High density sphere culture of adult cardiac cells increases the levels of cardiac and progenitor markers and shows signs of vasculogenesis. BioMed Res Int 2013: 696837.
37.
Wang, T., Z. Xu, W. Jiang, A. Ma (2006) Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 109: 74-81.
38.
Wojakowski, W., M. Tendera, M. Kucia, E. Zuba-Surma, E. Paczkowska, J. Ciosek, M. Halasa, M. Krol, M. Kazmierski, P. Buszman, A. Ochala, J. Ratajczak, B. Machalinski, M.Z. Ratajczak (2009) Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 53: 1-9.
39.
Zhou, Y., P. Pan, L. Yao, M. Su, P. He, N. Niu, M.A. McNutt, J. Gu (2010) CD117-positive cells of the heart: progenitor cells or mast cells? J Histochem Cytochem 58: 309-316.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.